Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting AMPK by Statins: A Potential Therapeutic Approach
Sajad Dehnavi, Amirhossein Kiani, Mahvash Sadeghi, et al.
Drugs (2021) Vol. 81, Iss. 8, pp. 923-933
Open Access | Times Cited: 76

Showing 26-50 of 76 citing articles:

Effect of statins on abdominal aortic aneurysm
Azar Hosseini, Toktam Sahranavard, Željko Reiner, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 178, pp. 106284-106284
Open Access | Times Cited: 13
Promising small molecule anti-fibrotic agents: Newly developed or repositioned drugs targeting myofibroblast transdifferentiation
Shin Ishikane, Masaki Arioka, Fumi Takahashi‐Yanaga
Biochemical Pharmacology (2023) Vol. 214, pp. 115663-115663
Open Access | Times Cited: 8
Acute, next‐generation AMPK activation initiates a disease‐resistant gene expression program in dystrophic skeletal muscle
Sean Y. Ng, Andrew I. Mikhail, Stephanie R. Mattina, et al.
The FASEB Journal (2023) Vol. 37, Iss. 5
Open Access | Times Cited: 7
Activation of AMPK pathway by low‑dose donafenib and atorvastatin combination improves high‑fat diet‑induced metabolic dysfunction‑associated steatotic liver disease
Yaowei Bai, Kequan Chen, Jia‐Cheng Liu, et al.
Molecular Medicine Reports (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 2
Identification and analysis of the molecular targets of statins in colorectal cancer
Ali Ahmadizad Firouzjaei, Ali Mahmoudi, Wael Almahmeed, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155258-155258
Closed Access | Times Cited: 2
Investigational agents for autosomal dominant polycystic kidney disease: preclinical and early phase study insights
Irene Capelli, Sarah Lerario, Francesca Ciurli, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 5, pp. 469-484
Closed Access | Times Cited: 2
Pitavastatin sensitizes the EGFR-TKI associated resistance in lung cancer by inhibiting YAP/AKT/BAD-BCL-2 pathway
Jie Liu, Jialei Fu, Ping Fu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Statins and peripheral neuropathy in diabetic and non-diabetic cases: a systematic review
Mahla Daliri, Thomas P. Johnston, Amirhossein Sahebkar
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 5, pp. 593-611
Open Access | Times Cited: 6
Don’t Judge a Book by Its Cover: The Role of Statins in Liver Cancer
Natalia Piekuś-Słomka, Lavinia Patricia Mocan, Rezarta Shkreli, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5100-5100
Open Access | Times Cited: 6
Antiangiogenic Drugs in NASH: Evidence of a Possible New Therapeutic Approach
Paola Orlandi, Anna Solini, Marta Banchi, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 995-995
Open Access | Times Cited: 13
Role of statins in regulating molecular pathways following traumatic brain injury: A system pharmacology study
Ali Mahmoudi, Sahar Heydari, Yuliya V. Markina, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113304-113304
Open Access | Times Cited: 10
mTORC1 syndrome (TorS): unified paradigm for diabetes/metabolic syndrome
Jacob Bar‐Tana
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 3, pp. 135-145
Open Access | Times Cited: 5
Effects of the Prior Use of Statins on Head and Neck Cancer Risk: A Hospital-Based Case–Control Study
Constanza Saka‐Herrán, Enric Jané Salas, António Mano Azul, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 579-579
Open Access | Times Cited: 9
The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials
Seyyed Mostafa Arabi, Mahla Chambari, Mahsa Malekahmadi, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 5, pp. 1597-1615
Closed Access | Times Cited: 9
Modulation of the miR-122/Sirt-6/ACE2 axis on experimentally-induced myocardial infarction
Zeinab M. Abdel-Nasser, Mai A. Zaafan, Amr M. Abdelhamid
Chemico-Biological Interactions (2022) Vol. 369, pp. 110276-110276
Closed Access | Times Cited: 9
Association between Oxidative Burden and Restenosis: A Case-Control Study
Shiva Ganjali, Atena Mansouri, Mitra Abbasifard, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 8
Genomic Insights Into Statin Therapy: Differential Expression Analysis of Key Genes
Maryam Mahjoubin‐Tehran, Vasily N. Sukhorukov, Tannaz Jmaialahmadi, et al.
Current Problems in Cardiology (2023) Vol. 49, Iss. 1, pp. 102103-102103
Closed Access | Times Cited: 4
ETC-1002 Attenuates Porphyromonas gingivalis Lipopolysaccharide-Induced Inflammation in RAW264.7 Cells via the AMPK/NF-κB Pathway and Exerts Ameliorative Effects in Experimental Periodontitis in Mice
Hong-yan Li, Peipei Zhang, Hongbing Lin, et al.
Disease Markers (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 7
Diabetic dyslipidemia impairs coronary collateral formation: An update
Ying Shen, Xiao Qun Wang, Yang Dai, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Berberine: Ins and outs of a nature-made PCSK9 inhibitor.
Sarina Ataei, Prashant Kesharwani, Amirhossein Sahebkar
PubMed (2022) Vol. 21, pp. 1099-1110
Closed Access | Times Cited: 7
Effect of Statins on the Blood Lipid Profile in Patients with Different Cardiovascular Diseases: A Systematic Review with Meta-analysis of Randomized Clinical Trials
Saeed Aslani, Bahman Razi, Danyal Imani, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 32, pp. 3702-3724
Closed Access | Times Cited: 7
A comprehensive assessment of the association between common drugs and psychiatric disorders using Mendelian randomization and real-world pharmacovigilance database
Zhuohui Chen, Xiang Wang, Ziwei Teng, et al.
EBioMedicine (2024) Vol. 107, pp. 105314-105314
Open Access | Times Cited: 1
A Spatiotemporally Controlled and Mitochondria-Targeted Prodrug of Hydrogen Sulfide Enables Mild Mitochondrial Uncoupling for the Prevention of Lipid Deposition
Xian Zhang, Mengjie Ye, Yuxin Ge, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 19188-19199
Closed Access | Times Cited: 1
Statins for vascular dementia: A hype or hope
Hamesh Gundala Raja, Hayder M. Al‐kuraishy, Mustafa M Shokr, et al.
Neuroscience (2024) Vol. 567, pp. 45-55
Open Access | Times Cited: 1
[Honokiol reduces doxorubicin-induced cardiotoxicity in vitro by inhibiting pyroptosis via activating AMPK/Nrf2 signaling].
Fuqin Xiong, Roujun Liu, Yuqing Li, et al.
PubMed (2022) Vol. 42, Iss. 8, pp. 1205-1211
Closed Access | Times Cited: 6

Scroll to top